MDL | MFCD30187514 |
---|---|
Molecular Weight | 475.58 |
Molecular Formula | C22H25N3O5S2 |
SMILES | COC1=CC=C(C2=C(C)N=C(NC(C(C)(C)C)=O)S2)C=C1S(NC3=CC=C(O)C=C3)(=O)=O |
PI4KIIIbeta-IN-10 is a potent PI4KIIIβ inhibitor with an IC 50 of 3.6 nM.
IC50: 3.6 nM (PI4KIIIβ), 720 nM (PI3Kδ), ~1 µM (PI3KC2γ), ~10 µM (PI3Kα), ~3 µM (PI4KIIIα) [1]
PI4KIIIbeta-IN-10 (Compound 10) is a potent PI4KIIIβ inhibitor with very minor off-target inhibition of PI4KIIIβ related lipid kinases. PI4KIIIbeta-IN-10 shows weak inhibition of PI3KC2γ (IC 50 ~1 µM), PI3Kα (~10 µM), and PI4KIIIα (~3 µM), and <20% inhibition at concentrations up to 20 µM for PI4K2α, PI4K2β, and PI3Kβ [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 125 mg/mL ( 262.84 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.1027 mL | 10.5135 mL | 21.0270 mL |
5 mM | 0.4205 mL | 2.1027 mL | 4.2054 mL |
10 mM | 0.2103 mL | 1.0513 mL | 2.1027 mL |